This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom, United States
The drug OZEMPIC contains one active pharmaceutical ingredient (API):
1
|
UNII
53AXN4NNHX - SEMAGLUTIDE
|
|
Semaglutide is a GLP-1 receptor agonist. It acts in the same way as GLP-1 (a hormone produced in the gut) by increasing the amount of insulin that the pancreas releases in response to food. This helps with the control of blood glucose levels. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| OZEMPIC Solution for injection | MPI, EU: SmPC | European Medicines Agency (EU) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A10BJ06 | A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BJ Glucagon-like peptide-1 (GLP-1) analogues | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 12075M, 12080T |
| BR | Câmara de Regulação do Mercado de Medicamentos | 526619010010201, 526619010010301 |
| CA | Health Products and Food Branch | 02471469, 02471477 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 178-MBE-0221, 190-MBE-0421 |
| EE | Ravimiamet | 1764435, 1788509, 1788510, 1788521, 1788532, 1788543, 1873740, 1873751 |
| ES | Centro de información online de medicamentos de la AEMPS | 1171251003, 1171251005, 117251002 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 123895, 489034, 510642 |
| FR | Base de données publique des médicaments | 61400703, 63210923, 65766192 |
| GB | Medicines & Healthcare Products Regulatory Agency | 364709, 364712, 364715, 380747, 387200, 387202 |
| HK | Department of Health Drug Office | 66485, 66486, 66487 |
| IE | Health Products Regulatory Authority | 33700, 33701, 33702, 33703, 33704, 33705, 37706, 37707, 37708 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 8389, 8390, 8391 |
| IT | Agenzia del Farmaco | 046128017, 046128029, 046128031, 046128043, 046128056, 046128068, 046128070, 046128082 |
| JP | 医薬品医療機器総合機構 | 2499418G1028, 2499418G2024, 2499418G3020, 2499418G4027 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1085075, 1086013, 1086014, 1086015, 1086016, 1086017 |
| NL | Z-Index G-Standaard, PRK | 201650, 201677, 201693 |
| PL | Rejestru Produktów Leczniczych | 100401983, 100413822, 100413839 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W65785001, W65786001, W65786002, W65787001, W65787002 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699676950300, 8699676950317, 8699676950324, 8699676950362, 8699676950379 |
| US | FDA, National Drug Code | 0169-4130, 0169-4132, 0169-4136, 50090-5138, 70518-2143 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.